Racial/ethnic differences in hypertension prevalence, treatment, and control for outpatients in Northern California 2010-2012.
Abstract
BACKGROUND:
Hypertension (HTN) is a known major cardiovascular disease risk factor, but prevalence, treatment, and control of HTN among rapidly growing minority groups such as Asian Americans and Hispanics are unknown largely due to either underrepresentation in epidemiologic studies or aggregation of Asian American subgroups.
METHODS:
A three-year cross-section (2010-2012) of patients from a large ambulatory care setting in northern California was examined in the following subgroups: Asian Indian, Chinese, Filipino, Japanese, Korean, Vietnamese, Mexicans, non-Hispanic Blacks (NHBs), and non-Hispanic Whites (NHWs). We defined HTN as two separate nonemergent office visit blood pressure measurements ≥140/90mm Hg, physician diagnosis of HTN, or use of antihypertensive medications.
RESULTS:
A total of 208,985 patients were included in the study. Age-adjusted HTN prevalence ranged from 30.0% in Chinese women to 59.9% in Filipino men. Most minority subgroups had lower or similar odds of having HTN compared with NHWs, except for Filipinos and NHBs whose odds were significantly higher after adjusting for patient demographic and clinical characteristics. Asian Americans and NHBs were more likely to be treated for HTN compared with NHWs. Achievement of blood pressure control was lower among Filipino women (odds ratio = 0.82, 99% confidence interval 0.70-0.96) and NHB men (odds ratio = 0.73, 99% confidence interval 0.58-0.91), compared with NHW women and men.
CONCLUSIONS:
Substantial racial/ethnic variation in HTN prevalence, treatment, and control was found in our study population. Filipino and NHB women and men are at especially high risk for HTN and may have more difficulty in achieving adequate blood pressure control.
Related publications
View all publications- Berger JS, Bhatt DL, Cannon CP, Chen Z, Jiang L, Jones JB, Mehta SR, Sabatine MS, Steinhubl SR, Topol EJ, Berger PB.J Am Coll Cardiol. 54(21):1935-45. doi: 10.1016/j.jacc.2009.05.074.2009 Nov 17
- Rosas LG, Lv N, Azar KMJ, Xiao L, Hooker SP, Lewis MA, Zavella P, Venditti EM, Ma J.Contemp Clin Trials. pii: S1551-7144(17)30629-8. doi: 10.1016/j.cct.2018.02.019. [Epub ahead of print]2018 Mar 02
- Li J, Linnan L, Rose J, Hooker E, Boswell M, D'Angelo H, Harrington C.Prev Med. 53(3):207-8. doi: 10.1016/j.ypmed.2011.06.001. Epub 2011 Jun 13.2011 Sep 01
- Frank AT, Zhao B, Jose PO, Azar KM, Fortmann SP, Palaniappan LP.Circulation. 129(5):570-9. doi: 10.1161/CIRCULATIONAHA.113.005757. Epub 2013 Nov 5.2014 Feb 04
- Romanelli RJ1, Schiro TA, Jukes T, Wong KS, Ishisaka DY.Ann Pharmacother. 45(12):1473-82. doi: 10.1345/aph.1Q523. Epub 2011 Dec 6.2011 Dec 01




